Prospective Seroepidemiological Study of Hepatitis E Virus Infection in an Occupational Health‐Checkup Cohort in Mie Prefecture, Japan
Hepatology Research · 2026-11 · 56 (11) · 1606-1613
DOI: 10.1111/hepr.70233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology Research, online erschienen am 07.07.2026. Verfasst von Tatsunori Nakano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Fujita Health University Nanakuri Memorial Hospital, Tsu, Mie, Japan. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Aims
Reported cases of hepatitis E have increased in Japan; however, the true burden of hepatitis E virus (HEV) infection is likely underestimated due to the high proportion of asymptomatic infections. We prospectively evaluated anti‐HEV immunoglobulin G (IgG) seroprevalence, seroconversion‐based incidence, and questionnaire‐reported exposures in an occupational health‐checkup cohort in Mie Prefecture, central Japan.
Methods
A total of 608 individuals (189 men and 419 women) who underwent annual health checkups between fiscal years 2023 and 2025 were included. Serum anti‐HEV IgG was measured. At baseline, participants completed a 10‐item questionnaire on potential HEV‐related exposures. Incident infection was evaluated by identifying IgG seroconversion during follow‐up.
Results
Anti‐HEV IgG was detected in 5 of 608 participants (0.82%), all of whom were men (5/189, 2.65% vs. 0/419 women, 0%; p = 0.0028). Age was not significantly associated with IgG seropositivity. As no women were seropositive, exploratory age‐adjusted analyses were conducted among men only; no questionnaire item was significantly associated with IgG positivity. Sex differences were observed in reported consumption of pork liver/offal, pork tongue, and venison/wild boar meat. One participant seroconverted during follow‐up, corresponding to an incidence of 138 per 100,000 (1/724; 95% CI, 3–770) person‐years. The seroconverter reported frequent consumption of raw or undercooked pork products.
Conclusions
Anti‐HEV IgG seroprevalence was low in this relatively young, predominantly female cohort. However, prospective follow‐up identified incident infections, with an incidence consistent with previous domestic estimates, suggesting that a substantial proportion of the Japanese population remains at risk of HEV infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Fujita Health University Nanakuri Memorial Hospital, Tsu, Mie, Japan.
- Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.
- Department of Clinical Laboratory, Fujita Health University Nanakuri Memorial Hospital, Tsu, Mie, Japan.
ORCID-Profile: Tatsunori Nakano, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Nakano, T., Takahashi, M., Itani, Y., Suzaki, K., Tanaka, K., Fujimoto, R., Murata, K., & Okamoto, H. (2026). Prospective Seroepidemiological Study of Hepatitis E Virus Infection in an Occupational Health‐Checkup Cohort in Mie Prefecture, Japan. Hepatology Research, 56(11), 1606-1613. https://doi.org/10.1111/hepr.70233
Vancouver
Nakano T, Takahashi M, Itani Y, Suzaki K, Tanaka K, Fujimoto R, et al. Prospective Seroepidemiological Study of Hepatitis E Virus Infection in an Occupational Health‐Checkup Cohort in Mie Prefecture, Japan. Hepatology Research. 2026;56(11):1606-1613. doi:10.1111/hepr.70233
BibTeX
@article{Nakano2026,
author = {Nakano, Tatsunori and Takahashi, Masaharu and Itani, Yoshinori and Suzaki, Kiriha and Tanaka, Kaho and Fujimoto, Rune and Murata, Kazumoto and Okamoto, Hiroaki},
title = {Prospective Seroepidemiological Study of Hepatitis E Virus Infection in an Occupational Health‐Checkup Cohort in Mie Prefecture, Japan},
journal = {Hepatology Research},
year = {2026},
volume = {56},
number = {11},
pages = {1606--1613},
doi = {10.1111/hepr.70233}
}
EUVIMED